TOPLINE:A review of National Comprehensive Cancer Network (NCCN) guidelines found that most surveillance recommendations were based on low-level evidence and often ambiguous about frequency, duration, and patient-specific modifications.METHODOLOGY:Cancer surveillance aims to detect recurrence after curative treatment, but existing evidence shows no survival benefit from routine follow-up. Although concerns about an unfavorable risk-benefit balance have increased, […]
